|
Delayed
London S.E.
09:35:10 01/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 74.80 GBX | +1.08% |
|
+13.33% | -7.08% |
| 14/08 | EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows | AN |
| 13/08 | Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal | CI |
| Market Cap | 27.94M 37.86M 32.6M 30.61M 52.49M 3.6B 52.86M 363M 141M 1.83B 142M 139M 6.05B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 26.62M 36.07M 31.06M 29.16M 50.01M 3.43B 50.37M 346M 134M 1.74B 135M 132M 5.76B | EV / Sales 2026 * |
30.3x | EV / Sales 2027 * | 29.7x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Arecor Therapeutics plc
| 1 day | +1.08% | ||
| 1 week | +13.33% | ||
| Current month | +22.62% | ||
| 1 month | +22.62% | ||
| 3 months | +13.33% | ||
| 6 months | +3.89% | ||
| Current year | -7.08% |
| 1 week | 65 |  | 74.8 |
| 1 month | 55.27 | | 74.8 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 100 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 472 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 13/04/2021 |
David J. Ellam
DFI | Director of Finance/CFO | - | 18/11/2024 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Sarah Howell
BRD | Director/Board Member | 51 | 13/04/2021 |
Mohammad Fazeli
BRD | Director/Board Member | 61 | 01/09/2017 |
Andrew Richards
CHM | Chairman | 66 | 13/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/5/26 | Free | Chief Executive Officer | 160,000 | 0.4238% | ||
| 20/5/26 | Free | Executive/Senior Manager | 95,000 | 0.2516% | ||
| 20/5/26 | Free | Chief Financial Officer | 105,000 | 0.2781% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +13.33% | +17.80% | -60.63% | 37.86M | |
| +0.28% | -1.70% | +1.19% | +18.18% | 49.81B | |
| -1.11% | -2.84% | +420.04% | +505.15% | 44.06B | |
| -0.21% | +0.37% | +36.88% | +17.32% | 42.99B | |
| -1.95% | -3.33% | +8.29% | +73.25% | 40.88B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.11B | |
| -1.11% | -4.20% | +25.49% | +119.78% | 16.58B | |
| +6.10% | +4.40% | - | - | 17.27B | |
| +0.08% | -1.97% | +11.76% | +28.21% | 14.63B | |
| -1.12% | -3.46% | +76.50% | +39.37% | 13.76B | |
| Average | +0.17% | -0.02% | +68.48% | +87.50% | 27.31B | |
| Weighted average by Cap. | -0.20% | -1.49% | +88.90% | +122.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 878K 1.19M 1.02M 962K 1.65M 113M 1.66M 11.4M 4.44M 57.44M 4.47M 4.37M 190M | 1.05M 1.42M 1.23M 1.15M 1.97M 135M 1.99M 13.63M 5.3M 68.65M 5.34M 5.23M 227M |
| Net income | - | - |
| Net Debt | -1.32M -1.79M -1.54M -1.45M -2.48M -170M -2.5M -17.13M -6.67M -86.29M -6.71M -6.57M -286M | 3.2M 4.34M 3.74M 3.51M 6.02M 413M 6.06M 41.58M 16.18M 209M 16.3M 15.94M 693M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | GBX 74.80 | +1.08% | 24,796 |
| 28/08/26 | GBX 74.00 | +8.03% | 75,524 |
| 27/08/26 | GBX 68.50 | +3.79% | 34,553 |
| 26/08/26 | GBX 66.00 | 0.00% | 9,469 |
| 25/08/26 | GBX 66.00 | 0.00% | 2,650 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7400GBP
Average target price
2.755GBP
Spread / Average Target
+272.30%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
